January 30, 2024 YOKOHAMA, Japan – Nissan Motor Co., Ltd. today announced production, sales, and export figures for December 2023 and calendar year 2023. 1. Production Oct. 2023(vehicles) Year-on-yearchange (%) Jan. – Oct. 2023(vehicles) Year-on-yearchange (%) Jan. – Oct. 2022(vehicles) Passenger vehicles 56,268 +5.9 647,945 +28.6 503,791 Commercial vehicles 4,930 -14.6 70,582… Continue reading @Nissan: Nissan production, sales, and exports for December and 2023001274
Tag: Nissan
CHARGED UP: SHIFT TO E-MOBILITY AND THE EVOLUTION OF TRANSPORTATION | MarketsandMarkets™
CHICAGO, Jan. 29, 2024 /PRNewswire/ — In the rapidly evolving landscape of transportation, a revolutionary shift is taking place – the rise of e-mobility. As the world grapples with the challenges of climate change and seeks sustainable alternatives to traditional modes of transportation, E-mobility emerges as a powerful contender. This transformation is not merely confined… Continue reading CHARGED UP: SHIFT TO E-MOBILITY AND THE EVOLUTION OF TRANSPORTATION | MarketsandMarkets™
CHARGED UP: SHIFT TO E-MOBILITY AND THE EVOLUTION OF TRANSPORTATION | MarketsandMarkets™
CHICAGO, Jan. 29, 2024 /PRNewswire/ — In the rapidly evolving landscape of transportation, a revolutionary shift is taking place – the rise of e-mobility. As the world grapples with the challenges of climate change and seeks sustainable alternatives to traditional modes of transportation, E-mobility emerges as a powerful contender. This transformation is not merely confined… Continue reading CHARGED UP: SHIFT TO E-MOBILITY AND THE EVOLUTION OF TRANSPORTATION | MarketsandMarkets™
Renal Anemia Therapeutics Market to Record Growth of USD 2.08 billion from 2023 to 2028, Akebia Therapeutics Inc and Amgen Inc to emerge as Some of the Key Companies – Technavio
NEW YORK, Jan. 29, 2024 /PRNewswire/ — The renal anemia therapeutics market is estimated to grow by USD 2.08 billion during 2023-2028, growing at a CAGR of 7.59%. Akebia Therapeutics Inc and Amgen Inc to emerge as some of the major companies. Akebia Therapeutics Inc offers adadustat. The report includes information on the product launches, sustainability, and prospects of… Continue reading Renal Anemia Therapeutics Market to Record Growth of USD 2.08 billion from 2023 to 2028, Akebia Therapeutics Inc and Amgen Inc to emerge as Some of the Key Companies – Technavio
Renault cancels Ampere IPO but still launching 7 new models
French automaker Renault just canceled its planned IPO for its EV spinoff Ampere. While the IPO was scheduled for the first part of this year with an expected valuation of up to €10 billion ($10.47 billion), Renault says that market conditions aren’t optimal to make the move. The close of trading today in Europe brought… Continue reading Renault cancels Ampere IPO but still launching 7 new models
@Renault: Renault Group decides to cancel Ampere’s IPO and confirms its EV and software strategy000578
Press ReleaseJanuary 29, 2024 20240129_Press Release_Renault Group_Ampere IPO Cancellation_Strategy confirmation Renault Group decides to cancel Ampere’s IPO and confirms its EV and software strategy Boulogne-Billancourt, January 29, 2024 Renault Group has created Ampere, the only European EV and software pure player, with one goal: democratize EV in Europe faster than EV pure players. Since… Continue reading @Renault: Renault Group decides to cancel Ampere’s IPO and confirms its EV and software strategy000578
@Renault: Renault Group décide d’annuler l’introduction en bourse d’Ampere et confirme sa stratégie électrique et software000577
Communiqué de presse29 janvier 2024 20240129_Communiqué_Renault Group_Annulation IPO Ampere_Confirmation stratégie Renault Group décide d’annuler l’introduction en bourse d’Ampere et confirme sa stratégie électrique et software Boulogne-Billancourt, 29 Janvier 2024 Renault Group a créé Ampere, l’unique pure player européen du véhicule électrique et du software, avec pour unique objectif de démocratiser le véhicule électrique… Continue reading @Renault: Renault Group décide d’annuler l’introduction en bourse d’Ampere et confirme sa stratégie électrique et software000577
CHARGED UP: SHIFT TO E-MOBILITY AND THE EVOLUTION OF TRANSPORTATION | MarketsandMarkets™
CHICAGO, Jan. 29, 2024 /PRNewswire/ — In the rapidly evolving landscape of transportation, a revolutionary shift is taking place – the rise of e-mobility. As the world grapples with the challenges of climate change and seeks sustainable alternatives to traditional modes of transportation, E-mobility emerges as a powerful contender. This transformation is not merely confined… Continue reading CHARGED UP: SHIFT TO E-MOBILITY AND THE EVOLUTION OF TRANSPORTATION | MarketsandMarkets™
CHARGED UP: SHIFT TO E-MOBILITY AND THE EVOLUTION OF TRANSPORTATION | MarketsandMarkets™
CHICAGO, Jan. 29, 2024 /PRNewswire/ — In the rapidly evolving landscape of transportation, a revolutionary shift is taking place – the rise of e-mobility. As the world grapples with the challenges of climate change and seeks sustainable alternatives to traditional modes of transportation, E-mobility emerges as a powerful contender. This transformation is not merely confined… Continue reading CHARGED UP: SHIFT TO E-MOBILITY AND THE EVOLUTION OF TRANSPORTATION | MarketsandMarkets™
Renault Group decides to cancel Ampere’s IPO and confirms its EV and software strategy
Press Release January 29, 2024 20240129_Press Release_Renault Group_Ampere IPO Cancellation_Strategy confirmation Renault Group decides to cancel Ampere’s IPO and confirms its EV and software strategy Boulogne-Billancourt, January 29, 2024 Renault Group has created Ampere, the only European EV and software pure player, with one goal: democratize EV in Europe faster than EV pure players.… Continue reading Renault Group decides to cancel Ampere’s IPO and confirms its EV and software strategy